Wasmuth JC - Search Results

1

Administration of indinavir and low-dose ritonavir (800/100 mg twice daily) with food reduces nephrotoxic peak plasma levels of indinavir.

Aarnoutse RE, Wasmuth JC, Fätkenheuer G, Schneider K, Schmitz K, de Boo TM, Reiss P, Hekster YA, Burger DM, Rockstroh JK. Aarnoutse RE, et al. Among authors: wasmuth jc. Antivir Ther. 2003 Aug;8(4):309-14. Antivir Ther. 2003. PMID: 14518700 Clinical Trial.

2

Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks.

Wasmuth JC, Herhaus C, Römer K, Salzberger B, Kaiser R, Schliefer K, Voigt E, Rockstroh JK. Wasmuth JC, et al. AIDS. 2002 May 3;16(7):1077-8. doi: 10.1097/00002030-200205030-00018. AIDS. 2002. PMID: 11953478 No abstract available.

3

Lopinavir/ritonavir plus saquinavir in salvage therapy; pharmacokinetics, tolerability and efficacy.

la Porte CJ, Wasmuth JC, Schneider K, Rockstroh JK, Burger DM. la Porte CJ, et al. Among authors: wasmuth jc. AIDS. 2003 Jul 25;17(11):1700-2. doi: 10.1097/00002030-200307250-00018. AIDS. 2003. PMID: 12853756

4

Comparison of two reduced-dose regimens of indinavir (600 mg vs 400 mg twice daily) and ritonavir (100 mg twice daily) in healthy volunteers (COREDIR).

Wasmuth JC, la Porte CJ, Schneider K, Burger DM, Rockstroh JK. Wasmuth JC, et al. Antivir Ther. 2004 Apr;9(2):213-20. Antivir Ther. 2004. PMID: 15134183 Clinical Trial.

5

Chemokine mRNA levels in mononucleated cells of HIV-infected patients before and after initiation of PI- versus NNRTI-containing HAART.

Wasmuth JC, Nischalke HD, Jütte A, Fätkenheuer G, Salzberger B, Sauerbruch T, Spengler U, Rockstroh JK, Dumoulin FL. Wasmuth JC, et al. Antiviral Res. 2004 Mar;61(3):207-12. doi: 10.1016/j.antiviral.2003.11.003. Antiviral Res. 2004. PMID: 15168802 Clinical Trial.

6

[Splenic infarct in a patient with HIV infection].

Wasmuth JC, Rockstroh JK. Wasmuth JC, et al. Med Klin (Munich). 2005 Oct 15;100(10):683-5. doi: 10.1007/s00063-005-1094-1. Med Klin (Munich). 2005. PMID: 16220259 German. No abstract available.

7

Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals.

Vogel M, Bertram N, Wasmuth JC, Wyen C, Voigt E, Schwarze-Zander C, Sudhop T, Fätkenheuer G, Rockstroh JK, Reichel C. Vogel M, et al. Among authors: wasmuth jc. J Antimicrob Chemother. 2009 May;63(5):988-91. doi: 10.1093/jac/dkp044. Epub 2009 Mar 6. J Antimicrob Chemother. 2009. PMID: 19270314

8

[Long-term efficacy of second-line treatment of HIV infection after class change following virological failure on protease inhibitor-based therapy].

Brunner J, Seybold U, Gunsenheimer-Bartmeyer B, Hamouda O, Bogner JR; ClinSurv-Studiengemeinschaft (gleichwertiger Beitrag). Brunner J, et al. Dtsch Med Wochenschr. 2010 Jun;135(23):1166-70. doi: 10.1055/s-0030-1255124. Epub 2010 May 31. Dtsch Med Wochenschr. 2010. PMID: 20514595 German.

9

The treatment of patients with HIV.

Vogel M, Schwarze-Zander C, Wasmuth JC, Spengler U, Sauerbruch T, Rockstroh JK. Vogel M, et al. Among authors: wasmuth jc. Dtsch Arztebl Int. 2010 Jul;107(28-29):507-15; quiz 516. doi: 10.3238/arztebl.2010.0507. Epub 2010 Jul 12. Dtsch Arztebl Int. 2010. PMID: 20703338 Free PMC article. Review.

10

Late presentation for HIV diagnosis and care in Germany.

Zoufaly A, an der Heiden M, Marcus U, Hoffmann C, Stellbrink H, Voss L, van Lunzen J, Hamouda O; ClinSurv Study Group. Zoufaly A, et al. HIV Med. 2012 Mar;13(3):172-81. doi: 10.1111/j.1468-1293.2011.00958.x. Epub 2011 Nov 7. HIV Med. 2012. PMID: 22093171 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters